Literature DB >> 3435051

Oncogene activation in malignant transformation: a study of H-ras in human breast cancer.

D A Spandidos1.   

Abstract

Two types of oncogene activation can occur in tumors. Quantitative changes have been demonstrated in a variety of animal and human tumors using molecular hybridization and immunohistochemical analyses. Qualitative changes in oncogene expression have also been found in a variety of tumors. In this study the existence of point mutations and other genetic changes in the H-ras1 gene in human breast tumors is demonstrated using oligonucleotide hybridization analysis. The role of quantitative and qualitative changes in oncogene expression in the multistep process of cancer is evaluated in view of these new findings.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435051

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cells.

Authors:  N T Telang; R Narayanan; H L Bradlow; M P Osborne
Journal:  Breast Cancer Res Treat       Date:  1991-08       Impact factor: 4.872

Review 2.  Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Authors:  David N Danforth
Journal:  Breast Cancer (Auckl)       Date:  2016-08-17

Review 3.  Aberrant function of the Ras signal transduction pathway in human breast cancer.

Authors:  G J Clark; C J Der
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

Review 4.  Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the 'cerebral diabetes paradigm'.

Authors:  Janet K Brewer
Journal:  J Mol Neurosci       Date:  2008-06-18       Impact factor: 3.444

Review 5.  Genetically engineered mice as experimental tools to dissect the critical events in breast cancer.

Authors:  Mitchell E Menezes; Swadesh K Das; Luni Emdad; Jolene J Windle; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

6.  Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene.

Authors:  Miljana Tanic; Kira Yanowsky; Cristina Rodriguez-Antona; Raquel Andrés; Iván Márquez-Rodas; Ana Osorio; Javier Benitez; Beatriz Martinez-Delgado
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

7.  Conserved cis-elements bind a protein complex that regulates Drosophila ras2/rop bidirectional expression.

Authors:  K Lightfoot; L Maltby; R Duarte; R Veale; O Segev
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

8.  p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.

Authors:  Emanuela Guerra; Alessia Cimadamore; Pasquale Simeone; Giovanna Vacca; Rossano Lattanzio; Gerardo Botti; Valentina Gatta; Marco D'Aurora; Barbara Simionati; Mauro Piantelli; Saverio Alberti
Journal:  BMC Cancer       Date:  2016-08-18       Impact factor: 4.430

9.  Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors.

Authors:  G Scambia; L Catozzi; P Benedetti Panici; G Ferrandina; G Almadori; G Paludetti; G Cadoni; M Distefano; A Piffanelli; S Mancuso
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.